Cullinan Oncology Inc
NASDAQ:CGEM

Watchlist Manager
Cullinan Oncology Inc Logo
Cullinan Oncology Inc
NASDAQ:CGEM
Watchlist
Price: 7.295 USD 3.77% Market Closed
Market Cap: 430.5m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of CGEM.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CGEM Intrinsic Value
Not Available
Base Case Scenario
Compare CGEM to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CGEM?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Cullinan Oncology Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cullinan Oncology Inc

Current Assets 275.9m
Cash & Short-Term Investments 265.5m
Other Current Assets 10.4m
Non-Current Assets 244.4m
Long-Term Investments 242.3m
PP&E 1.7m
Other Non-Current Assets 367k
Efficiency

Free Cash Flow Analysis
Cullinan Oncology Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cullinan Oncology Inc

Revenue
0 USD
Operating Expenses
-234.7m USD
Operating Income
-234.7m USD
Other Expenses
27.9m USD
Net Income
-206.8m USD
Fundamental Scores

CGEM Profitability Score
Profitability Due Diligence

Cullinan Oncology Inc's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Declining ROE
22/100
Profitability
Score

Cullinan Oncology Inc's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

CGEM Solvency Score
Solvency Due Diligence

Cullinan Oncology Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Cullinan Oncology Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CGEM Price Targets Summary
Cullinan Oncology Inc

Wall Street analysts forecast CGEM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CGEM is 29.453 USD with a low forecast of 22.22 USD and a high forecast of 36.75 USD.

Lowest
Price Target
22.22 USD
205% Upside
Average
Price Target
29.453 USD
304% Upside
Highest
Price Target
36.75 USD
404% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Cullinan Oncology Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CGEM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CGEM Insider Trading
Buy and sell transactions by insiders